If you think Big Pharma isn't struggling, you haven't payed close enough attention. There is a bit of a crisis in innovation that is commonly blamed on the low-hanging fruit being gone. To cope, almost all of the big US companies have cut their discovery and preclinical teams significantly. In their place companies are paying contract companies to do large chunks of the more monotonous chunks of research or buying assets that are already developed to clinical candidate from academia or small biotechs.

That sounds more like an industry with an unsustainable business model adapting and converting to a sustainable crowdsourced model.

"struggling" isn't the word I would use in this situation.

Things change, oil dries up. Doesn't mean we need to start making redflag laws to protect the old models.

And yet they have enough money to get the influence to get the US government to strongarm other governments through treaties. That's not cheap.

I do hear what you say about the font drying up, but it's also no secret that medication is ridiculously expensive in the US. Big pharma is very wealthy, and very politically powerful, despite the low-hanging fruit being gone. The point I'm trying to make is that they don't need a treaty to protect them.